| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.075 | 0.1 |